Concepedia
Statistics
Publications
27
Citations
963
H-Index
17
Active since
2000
Affiliations
Procter & Gamble (United States)(Current)
Takeda (United States)
Aptuit (Italy)
Wayne State University
University of Washington
M. Sabat is an author at Procter & Gamble (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.
Publications per year
2000–2024
Development of Orally Bioavailable Bicyclic Pyrazolones as Inhibitors of Tumor Necrosis Factor-α Production
Michael P. Clark, Steven K. Laughlin, Matthew J. Laufersweiler et al. · Journal of Medicinal Chemistry · 2004 · 131 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +8
Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton’s Tyrosine Kinase
Christopher R. Smith, Douglas R. Dougan, Mallareddy Komandla et al. · Journal of Medicinal Chemistry · 2015 · 74 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Structures of the TRPM5 channel elucidate mechanisms of activation and inhibition
Zheng Ruan, Emery Haley, Ian J. Orozco et al. · Nature Structural & Molecular Biology · 2021 · 71 citations · Full text
Natural Sciences, Biophysics, Neurobiology +12
Synthesis of Unnatural Amino Acids via Suzuki Cross-Coupling of Enantiopure Vinyloxazolidine Derivatives
M. Sabat, Carl R. Johnson · Organic Letters · 2000 · 70 citations
Natural Sciences, Chemistry, Biocatalysis +13
The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)
M. Sabat, John C. VanRens, Matthew J. Laufersweiler et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 68 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +8
1–5 of 27